Farrell G - Search Results

1

Independent effects of physical activity in patients with nonalcoholic fatty liver disease.

St George A, Bauman A, Johnston A, Farrell G, Chey T, George J. St George A, et al. Among authors: farrell g. Hepatology. 2009 Jul;50(1):68-76. doi: 10.1002/hep.22940. Hepatology. 2009. PMID: 19444870 Clinical Trial.

2

Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.

St George A, Bauman A, Johnston A, Farrell G, Chey T, George J. St George A, et al. Among authors: farrell g. J Gastroenterol Hepatol. 2009 Mar;24(3):399-407. doi: 10.1111/j.1440-1746.2008.05694.x. Epub 2008 Dec 2. J Gastroenterol Hepatol. 2009. PMID: 19067776 Clinical Trial.

3

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response.

Kumar D, Farrell GC, Fung C, George J. Kumar D, et al. Hepatology. 2002 Nov;36(5):1266-72. doi: 10.1053/jhep.2002.36370. Hepatology. 2002. PMID: 12395339

4

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, Hall P, Khan M, George J. Hui JM, et al. Among authors: farrell gc. Hepatology. 2003 Aug;38(2):420-7. doi: 10.1053/jhep.2003.50320. Hepatology. 2003. PMID: 12883486

5

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Hui JM, et al. Among authors: farrell gc. Hepatology. 2004 Jul;40(1):46-54. doi: 10.1002/hep.20280. Hepatology. 2004. PMID: 15239085

6

HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.

Chitturi S, Weltman M, Farrell GC, McDonald D, Kench J, Liddle C, Samarasinghe D, Lin R, Abeygunasekera S, George J. Chitturi S, et al. Hepatology. 2002 Jul;36(1):142-9. doi: 10.1053/jhep.2002.33892. Hepatology. 2002. PMID: 12085358

7

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?

Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, Fung C, Liddle C, Samarasinghe D, George J. Chitturi S, et al. Among authors: farrell g. Hepatology. 2002 Aug;36(2):403-9. doi: 10.1053/jhep.2002.34738. Hepatology. 2002. PMID: 12143049

8

Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis.

George J, Pera N, Phung N, Leclercq I, Yun Hou J, Farrell G. George J, et al. Among authors: farrell g. J Hepatol. 2003 Nov;39(5):756-64. doi: 10.1016/s0168-8278(03)00376-3. J Hepatol. 2003. PMID: 14568258

9

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.

Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M, George J. Chitturi S, et al. Hepatology. 2002 Feb;35(2):373-9. doi: 10.1053/jhep.2002.30692. Hepatology. 2002. PMID: 11826411

10

Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.

Hui JM, Kench J, Farrell GC, Lin R, Samarasinghe D, Liddle C, Byth K, George J. Hui JM, et al. J Gastroenterol Hepatol. 2002 Aug;17(8):873-81. doi: 10.1046/j.1440-1746.2002.02813.x. J Gastroenterol Hepatol. 2002. PMID: 12164963

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

723 results

Search Page

Filters